Xentria, Inc.
Clinical trials sponsored by Xentria, Inc., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Can a new infusion drug tame lung inflammation and cut steroid use? Results expected Nov 2026 (estimated)
- Can a new fertility drug match the real thing? Results expected Mar 2027 (estimated)
-
New insulin put to the test against market leaders in healthy volunteers
Knowledge-focused CompletedThis study compared a new insulin called NKF-INS(L) with two already-approved insulins (US-Humalog and EU-Humalog) in 54 healthy men. The goal was to see if the new insulin is absorbed and works similarly in the body. Participants received a single dose of each insulin in random …
Phase 1 • Sponsor: Xentria, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:10 UTC
-
New insulin shows promise in healthy volunteers
Knowledge-focused CompletedThis study checked if a new insulin (NKF-INS(A)) is similar to two already-approved insulins (US-NovoLog and EU-NovoRapid). Fifty-four healthy men received a single dose of each insulin in random order. Researchers measured how fast the insulin entered the blood and how it contro…
Phase 1 • Sponsor: Xentria, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:13 UTC